Annual Shareholders Equity
$91.06 M
+$278.01 M+148.71%
December 31, 2023
Summary
- As of February 20, 2025, SGMT annual stockholders equity is $91.06 million, with the most recent change of +$278.01 million (+148.71%) on December 31, 2023.
- During the last 3 years, SGMT annual shareholders equity has risen by +$226.97 million (+167.00%).
- SGMT annual shareholders equity is now at all-time high.
Performance
SGMT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$170.68 M
-$12.61 M-6.88%
September 30, 2024
Summary
- As of February 20, 2025, SGMT quarterly stockholders equity is $170.68 million, with the most recent change of -$12.61 million (-6.88%) on September 30, 2024.
- Over the past year, SGMT quarterly shareholders equity has increased by +$79.62 million (+87.43%).
- SGMT quarterly shareholders equity is now -10.18% below its all-time high of $190.02 million, reached on March 31, 2024.
Performance
SGMT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SGMT Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +148.7% | +87.4% |
| 3 y3 years | +167.0% | +188.6% |
| 5 y5 years | +172.7% | +188.6% |
SGMT Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.7% | -10.2% | +186.0% |
| 5 y | 5-year | at high | +148.7% | -10.2% | +186.0% |
| alltime | all time | at high | +148.7% | -10.2% | +186.0% |
Sagimet Biosciences Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $170.68 M(-6.9%) |
| Jun 2024 | - | $183.29 M(-3.5%) |
| Mar 2024 | - | $190.02 M(+108.7%) |
| Dec 2023 | $91.06 M | $91.06 M(-7.0%) |
| Sep 2023 | - | $97.88 M(-149.3%) |
| Jun 2023 | - | -$198.41 M(+3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$192.70 M(+3.1%) |
| Dec 2022 | -$186.95 M(+18.1%) | -$186.95 M(+33.0%) |
| Dec 2021 | -$158.26 M(+16.4%) | - |
| Mar 2021 | - | -$140.58 M |
| Dec 2020 | -$135.91 M(+8.5%) | - |
| Dec 2019 | -$125.31 M | - |
FAQ
- What is Sagimet Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Sagimet Biosciences?
- What is Sagimet Biosciences annual shareholders equity year-on-year change?
- What is Sagimet Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sagimet Biosciences?
- What is Sagimet Biosciences quarterly shareholders equity year-on-year change?
What is Sagimet Biosciences annual stockholders equity?
The current annual shareholders equity of SGMT is $91.06 M
What is the all time high annual shareholders equity for Sagimet Biosciences?
Sagimet Biosciences all-time high annual stockholders equity is $91.06 M
What is Sagimet Biosciences annual shareholders equity year-on-year change?
Over the past year, SGMT annual stockholders equity has changed by +$278.01 M (+148.71%)
What is Sagimet Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of SGMT is $170.68 M
What is the all time high quarterly shareholders equity for Sagimet Biosciences?
Sagimet Biosciences all-time high quarterly stockholders equity is $190.02 M
What is Sagimet Biosciences quarterly shareholders equity year-on-year change?
Over the past year, SGMT quarterly stockholders equity has changed by +$79.62 M (+87.43%)